FOR IMMEDIATE RELEASE
25th July 2019
Paola - Malta
CPTM agrees Heads of Terms with global Healthcare management company
Cannapharm Technologies Malta Limited (“CPTM” or the “Company”) today agreed Heads of Terms with a major, global Healthcare management and related services company, for the supply of Medical Cannabis products. The first order will be processed and shipped directly from CPTM’s new EU-GMP certified facilities, currently under construction in Malta.
“This is a major milestone for CPTM” said Bruce H. Gaston, Director of CPTM. “This agreement will secure worldwide exposure for our products, through our partners’ extensive distribution network covering their own, as well as third-party healthcare facilities”.
Further information to be released in due course.
Bruce H. Gaston
Cannapharm Technologies Malta Limited (CPTM) is a limited company, registered under the Companies Act, 1995 of the Republic of Malta.
CPTM believes in long-term, incremental growth, based on the latest technological advances. It works closely with governments, regulatory authorities and local municipalities, to utilise, integrate and grow existing local infrastructures, within the framework of regional and governmental development programs and targets.
As an EU-based enterprise, CPTM adheres to and implements the strictest of standards in its productions, whilst maintaining a result-driven, qualitative approach to its pharmaceutical operations in Europe and Asia.